Finance Home - My Yahoo - Yahoo! - Help

Tuesday, November 10, 2009, 4:00AM ET - U.S. Markets open in 5 hours and 30 minutes. Dow  2.03% Nasdaq  0.00%

PDL BioPharma, Inc. (PDLI)

On Nov 9: 8.19   0.00 (0.00%)

MORE ON PDLI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Nov 9, 2009 • Two Stocks with Market Caps Over $250 Million That Sell for Under $10 at Seeking Alpha (Mon 6:23am) • PDL BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon 6:03am) Sat, Nov 7, 2009 • Genmab to cut 130 jobs in Brooklyn Park, sell biotech factory at bizjournals.com (Sat, Nov 7) Fri, Nov 6, 2009 • PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disp EDGAR Online (Fri, Nov 6) Thu, Nov 5, 2009 • UPDATE - Genmab US plant sale, job cuts to hit year results at Reuters (Thu, Nov 5) Tue, Nov 3, 2009 • PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online (Tue, Nov 3) Mon, Nov 2, 2009 • PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction PR Newswire (Mon, Nov 2) Wed, Oct 28, 2009 • PDL BioPharma Q3 2009 Earnings Call Transcript at Seeking Alpha (Wed, Oct 28) • PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina EDGAR Online (Wed, Oct 28) • PDL BioPharma, Inc. Earnings Call scheduled for 8:30 am ET today CCBN (Wed, Oct 28) • PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction PR Newswire (Wed, Oct 28) • PDL BioPharma Announces Third Quarter 2009 Financial Results PR Newswire (Wed, Oct 28) • Q3 2009 PDL BioPharma, Inc. Earnings Release - Before Market Open CCBN (Wed, Oct 28) Tue, Oct 27, 2009 • PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009 PR Newswire (Tue, Oct 27) • PDL BioPharma Reschedules Third Quarter 2009 Financial Results Conference Call for 8:30 a.m. ET on October 28, 2009 PR Newswire (Tue, Oct 27) Thu, Oct 22, 2009 • PDL BioPharma to Announce Third Quarter 2009 Financial Results and Hold Conference Call October 28, 2009 PR Newswire (Thu, Oct 22) Wed, Oct 21, 2009 • PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online (Wed, Oct 21) Tue, Oct 20, 2009 • Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst Wall Street Transcript (Tue, Oct 20) • New Formulation Of Diclofenac Successful In Two Phase III Trials, Approval Will Be Catalyst For Stock According To Industry Expert Wall Street Transcript (Tue, Oct 20) • "Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst Wall Street Transcript (Tue, Oct 20) Older Headlines - Download Recent Headlines View headlines from: Tue, Oct 20, 2009Tue, Oct 13, 2009Tue, Oct 6, 2009Tue, Sep 29, 2009Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009Tue, Sep 1, 2009Tue, Aug 25, 2009Tue, Aug 18, 2009 Add PDLI News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage